• Return to Headlines

Tetraphase Pharm: New 52-Week Low Set Today (TTPH)

By Shiri Gupta

Tetraphase Pharm (NASDAQ:TTPH) traded today at a new 52-week low of $0.77. So far today approximately 79,000 shares have been exchanged, as compared to an average 30-day volume of 455,000 shares.

In the past 52 weeks, Tetraphase Pharm share prices have been bracketed by a current low of $0.77 and a high of $4.49 and are now at $0.77. Over the past week, the 200-day moving average (MA) has gone down 1.6% while the 50-day MA has declined 2.3%.

Tetraphase Pharmaceuticals, Inc. biopharmaceutical products. The Company offers antibiotics to treat multi-drug resistant bacterial infections. Tetraphase Pharmaceuticals serves customers in the United States.

There is potential upside of 810.5% for shares of Tetraphase Pharm based on a current price of $0.77 and an average consensus analyst price target of $7.00. The stock should run into initial resistance at its 50-day moving average (MA) of $1.14 and subsequent resistance at its 200-day MA of $1.83.

SmarTrend is tracking the current trend status for Tetraphase Pharm and will alert subscribers who have TTPH in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows tetraphase pharm

Ticker(s): TTPH